Nasdaq

Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3

SALT LAKE CITY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a research collaboration with the National ...
Seeking Alpha

Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic ...

BALTIMORE, Md. and MONTREAL, July 29, 2024 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics (DGX) company, announced today a research collaboration with Dr. Simon Turcotte, ...
Hosted on MSN

Guelph General Hospital begins using Sectra’s digital pathology module

Guelph General Hospital in Canada has started using Sectra's digital pathology module to improve its diagnostic capabilities and workflow efficiency. The hospital has integrated the module into its ...